PHGDH and invasive breast carcinoma: demonstrated that BrCa cell lines intrinsically overexpressing PHGDH are uniquely sensitive to its knockdown, whereas others are insensitive, suggesting that PHGDH inhibitors may have cancer cell survival in their crosshairs.